Literature DB >> 25785097

A novel tissue-engineered bone in repairing femoral head defect and necrosis.

Wuxun Peng1, Lei Wang1, Jian Zhang1, Jin Deng1, Yuekun Gong2, Shihe Li2, Yunyu Hu3.   

Abstract

OBJECTIVE: To evaluate the therapeutic effects of AACB/BMP/bFGF, a novel tissue-engineered bone, in repairing femoral head defect and necrosis in dog models.
METHODS: Dog models of avascular necrosis of femoral head (ANFH) were established by liquid nitrogen freezing method. Group A was untreated; Groups B, C, and D were implanted with AACB, AACB/BMP, and AACB/BMP/bFGF complex, respectively; Group E was grafted with autologous cancellous bone. Samples were collected at 3 w, 6 w, and 12 w after operation. A series of examinations were carried out to investigate the effects of the materials in repairing femoral head defect, including anatomical observation, X-ray examination, histological analysis, and vascular immunohistochemical staining.
RESULTS: Our results indicated that, compared with AACB alone and AACB/BMP, AACB/BMP/bFGF complex could exert the most efficient therapeutic effects in dog ANFH models. X-ray examination further confirmed that AACB/BMP/bFGF complex could effectively repair the injuries in dog ANFH models, almost to a comparable level with cancellous bone autografts. Moreover, histological analysis indicated that AACB/BMP/bFGF complex greatly enhanced the new bone formation, which would contribute to the healing of ANFH. Furthermore, vascular immunohistochemical staining revealed that AACB/BMP/bFGF complex could significantly stimulate the revascularization in defect areas, reflecting the post-injury healing process in these models.
CONCLUSION: AACB/BMP/bFGF complex has great potential in repairing femoral head defect by enhancing osteogenesis and revascularization. The novel tissue-engineered bone would be widely used in clinical applications for ANFH treatment, especially as an alternative for autografts.

Entities:  

Keywords:  Avascular necrosis of femoral head; allogeneic antigen-extracted cancellous bone; basic fibroblast growth factor; bone morphogenetic protein

Year:  2015        PMID: 25785097      PMCID: PMC4358552     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  19 in total

1.  Effect of immunization with polyvinylpyrrolidone on the counts of stromal precursor cells in bone marrow and spleen of CBA and CBA/N mice and cytokine gene expression in primary cultures of these cells.

Authors:  U F Gorskaya; T A Danilova; M V Mezentzeva; M M Shapoval; V G Nesterenko
Journal:  Bull Exp Biol Med       Date:  2012-05       Impact factor: 0.804

2.  Effect of several growth factors on canine flexor tendon fibroblast proliferation and collagen synthesis in vitro.

Authors:  Stavros Thomopoulos; Fred L Harwood; Matthew J Silva; David Amiel; Richard H Gelberman
Journal:  J Hand Surg Am       Date:  2005-05       Impact factor: 2.230

3.  Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2.

Authors:  Bing Chen; Hang Lin; Jianhua Wang; Yannan Zhao; Bin Wang; Wenxue Zhao; Wenjie Sun; Jianwu Dai
Journal:  Biomaterials       Date:  2006-11-13       Impact factor: 12.479

4.  Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization.

Authors:  Shingo Nakamura; Masaki Nambu; Takamitsu Ishizuka; Hidemi Hattori; Yasuhiro Kanatani; Bonpei Takase; Satoko Kishimoto; Yoshiko Amano; Hiroshi Aoki; Tomoharu Kiyosawa; Masayuki Ishihara; Tadaaki Maehara
Journal:  J Biomed Mater Res A       Date:  2008-06-01       Impact factor: 4.396

5.  Mosaicplasty associated with gene enhanced tissue engineering for the treatment of acute osteochondral defects in a goat model.

Authors:  Jun Sun; Xiao-Kui Hou; Xu Li; Ting-Ting Tang; Ru-Ming Zhang; Yong Kuang; Meng Shi
Journal:  Arch Orthop Trauma Surg       Date:  2008-10-07       Impact factor: 3.067

6.  In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments.

Authors:  Mathew Varkey; Cezary Kucharski; Takrima Haque; Walter Sebald; Hasan Uludağ
Journal:  Clin Orthop Relat Res       Date:  2006-02       Impact factor: 4.176

7.  BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering.

Authors:  Ye Ji; Gong Ping Xu; Zhi Peng Zhang; Jing Jun Xia; Jing Long Yan; Shang Ha Pan
Journal:  Ann Biomed Eng       Date:  2010-01-05       Impact factor: 3.934

8.  The effect of growth factor treatment on meniscal chondrocyte proliferation and differentiation on polyglycolic acid scaffolds.

Authors:  K Stewart; M Pabbruwe; S Dickinson; T Sims; A P Hollander; J B Chaudhuri
Journal:  Tissue Eng       Date:  2007-02

9.  New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat model.

Authors:  Mohammad Amin Kerachian; Denis Cournoyer; Edward J Harvey; Terry Y Chow; Louis R Bégin; Ayoub Nahal; Chantal Séguin
Journal:  Arthritis Res Ther       Date:  2010-06-25       Impact factor: 5.156

10.  Effect of growth factors (BMP-4/7 & bFGF) on proliferation & osteogenic differentiation of bone marrow stromal cells.

Authors:  Shaohui Yuan; Qi Pan; Chun Jiang Fu; Zhenggang Bi
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

View more
  1 in total

1.  Effect of bone mesenchymal stem cells transplantation on the micro-environment of early osteonecrosis of the femoral head.

Authors:  Huanjin Song; Li Tao; Fang Wang; Weizhuo Wang; Yongchang Wei; Wenjun Shen; Fuling Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.